SchromKP, KobsA, NedorostS. Clinical psoriasiform dermatitis following dupilumab use for autoeczematization secondary to chronic stasis dermatitis. Cureus, 2020; 12(4):e7831. Published April 25, 2020. doi:10.7759/cureus.7831.
2.
TsaiM, ThaulandTJ, HuangAY, et al.Disseminated coccidioidomycosis treated with interferon-γ and dupilumab. N Engl J Med, 2020; 382(24):2337–2343. doi:.
3.
FlemingP, DruckerAM. Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials. J Am Acad Dermatol, 2018; 78(1):62–69.e1. doi:.
4.
BlauveltA, SimpsonEL, TyringSK, et al.Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis. J Am Acad Dermatol, 2019; 80(1):158–167.e1.
